PRTA · PROTHENA CORP PUBLIC LTD CO
Prothena Corporation plc, a late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation. Its product pipeline includes Prasinezumab, an investigational humanized monoclonal antibody which is in Phase 3 clinical trial for the treatment of parkinson's disease and other synucleinopathies. The company also develops Coramitug, an investigational antibody, which is in Phase 3 clinical trial for the treatment of transthyretin amyloidosis; BMS-986446, an anti-tau antibody which is in Phase 2 clinical trial to treat Alzheimer's disease; PRX019, an investigational antibody which is in Phase 1 clinical trial for the treatment of neurodegenerative diseases; and PRX123, a Dual Aß-Tau Vaccine, which is in preclinical trial for treating Alzheimer's disease. In addition, it develops discovery- and late-preclinical-stage programs include TDP-43 CYTOPE for the treatment of amyotrophic lateral sclerosis; PRX012, a next-generation anti-Aß antibody which is in phase 1 clinical trial to treat Alzheimer's disease; and PRX012-TfR, a preclinical program for the treatment of Alzheimer's disease. It has a license, development, and commercialization agreement with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. to develop and commercialize antibodies that target a-synuclein, including prasinezumab; and master collaboration agreement with Bristol Myers Squibb to develop and commercialize antibodies targeting tau, TDP-43. Prothena Corporation plc was incorporated in 2012 and is based in Dublin, Ireland.
Cap structure and valuation
| Cap structure | |
|---|---|
| SP | $9.12 |
| SO | 51.3M |
| Options | 11.8M |
| Warrants | 0.0M |
| FD SO | 63.1M |
| MC | $575.5M |
| Cash | $288.2M |
| Total debt | — |
| EV | $287.3M |
| TTM Multiples | |
|---|---|
| EV / Revenue | 5.3x |
| EV / EBITDA | — |
| MC / Net Income | — |
| EV / FCF | — |
| MC / FCF | — |
| Ownership & coverage | |
|---|---|
| Institutional | 93.3% |
| Insiders | 20.5% |
| # Institutions | 257 |
| Analysts | 5 |
| Consensus | Buy |
| Avg target | $21.40 |
| Short % float | 18.8% |
| Days to cover | 12.84 |
MC = SP × FD SO. EV = MC + Debt − Cash. SP = previous yfinance close. Balance-sheet figures as of 2026-07-30. Multiples use TTM (sum of last 4 quarters); shown as "—" when the denominator is zero or negative, or when fewer than four quarters are reported — a partial sum is not a trailing twelve months. Ownership & coverage per Yahoo Finance as of 2026-08-11 — institutional % is 13F-based, so it can lag a quarter and exceed 100% on share-count timing. Short interest per FINRA bi-monthly reporting, as of 2026-07-15; the float denominator can be unreliable on tiny floats.
Financial statements
| 6/30/26 | 3/31/26 | 12/31/25 | 9/30/25 | |
|---|---|---|---|---|
| Total Revenue | 1.01 | 51.08 | 0.02 | 2.42 |
| Revenue YoY % | (77.1%) | 1706.4% | (99.0%) | 149.0% |
| Gross Profit | — | 42.70 | — | — |
| Gross Margin % | — | 83.6% | — | — |
| SG&A | 10.90 | 12.67 | 12.65 | 13.24 |
| R&D | 8.80 | 12.63 | 14.59 | 28.94 |
| Operating Income | (21.10) | 30.04 | (24.20) | (40.24) |
| Operating Income YoY % | 75.1% | 145.8% | 62.7% | 39.5% |
| Operating Margin % | (2089.2%) | 58.8% | (115252.4%) | (1666.3%) |
| EBITDA | (20.90) | 30.22 | (23.98) | (40.01) |
| EBITDA Margin % | (2069.7%) | 59.2% | (114214.3%) | (1656.8%) |
| Interest Expense | 2.55 | 2.42 | 2.65 | 3.35 |
| Other Income / (Expense) | 5.07 | 5.10 | 5.27 | 6.68 |
| Pretax Income | (18.58) | 32.72 | (21.58) | (36.91) |
| Tax Provision | 0.00 | 0.00 | 0.01 | (0.37) |
| Net Income | (18.58) | 32.72 | (21.59) | (36.54) |
| Net Margin % | (1839.9%) | 64.1% | (102804.8%) | (1513.1%) |
| Diluted EPS | -$0.36 | $0.60 | -$0.40 | -$0.68 |
| Basic EPS | -$0.36 | $0.61 | -$0.40 | -$0.68 |
| Diluted Avg Shares | 52.1 | 54.1 | — | 53.8 |
| Basic Avg Shares | 52.1 | 53.7 | — | 53.8 |
| LTM | 12/31/25 | 12/31/24 | 12/31/23 | 12/31/22 | |
|---|---|---|---|---|---|
| Total Revenue | 54.53 | 9.68 | 135.16 | 91.37 | 53.91 |
| Revenue YoY % | 463.1% | (92.8%) | 47.9% | 69.5% | — |
| SG&A | 49.45 | 59.39 | 67.20 | 61.84 | 49.90 |
| R&D | 64.95 | 134.85 | 222.52 | 220.57 | 135.56 |
| Operating Income | (55.51) | (214.64) | (154.56) | (191.04) | (131.56) |
| Operating Income YoY % | 74.1% | (38.9%) | 19.1% | (45.2%) | — |
| Operating Margin % | (101.8%) | (2216.4%) | (114.4%) | (209.1%) | (244.1%) |
| EBITDA | (54.68) | (213.75) | (153.67) | (190.11) | (130.81) |
| EBITDA Margin % | (100.3%) | (2207.2%) | (113.7%) | (208.1%) | (242.7%) |
| Interest Expense | 10.97 | 14.14 | 25.82 | 31.01 | 6.35 |
| Other Income / (Expense) | 22.12 | 27.95 | 51.45 | 61.57 | 12.30 |
| Pretax Income | (44.35) | (200.83) | (128.93) | (160.48) | (125.61) |
| Tax Provision | (0.36) | 43.26 | (6.62) | (13.45) | (8.66) |
| Net Income | (43.99) | (244.09) | (122.31) | (147.03) | (116.95) |
| Net Margin % | (80.7%) | (2520.6%) | (90.5%) | (160.9%) | (217.0%) |
| Diluted EPS | -$0.84 | -$4.53 | -$2.27 | -$2.76 | -$2.47 |
| Basic EPS | -$0.83 | -$4.53 | -$2.27 | -$2.76 | -$2.47 |
| Diluted Avg Shares | 52.1 | 53.8 | 53.8 | 53.2 | 47.4 |
| Basic Avg Shares | 52.1 | 53.8 | 53.8 | 53.2 | 47.4 |
| 6/30/26 | 3/31/26 | 12/31/25 | 9/30/25 | |
|---|---|---|---|---|
| Cash & Equivalents | 288.19 | 329.46 | 307.53 | 330.84 |
| Other Current Assets | 3.82 | 9.74 | 7.66 | 9.13 |
| Total Current Assets | 292.01 | 339.20 | 315.19 | 339.97 |
| Net PPE | 2.49 | 1.96 | 2.14 | 2.46 |
| Operating Lease ROU | 6.74 | 7.39 | 8.12 | 8.85 |
| Total Assets | 302.58 | 349.89 | 326.80 | 352.63 |
| Accounts Payable | 1.94 | 4.30 | 5.88 | 10.50 |
| Current Lease Liabilities | 2.96 | 2.89 | 2.89 | 2.88 |
| Other Current Liabilities | 6.76 | 25.32 | 32.08 | 38.05 |
| Total Current Liabilities | 11.66 | 32.52 | 40.84 | 51.44 |
| Long-term Lease Liabilities | 4.03 | 4.76 | 5.49 | 6.20 |
| Total Liabilities | 15.69 | 37.28 | 46.33 | 57.64 |
| Retained Earnings | (1,332.30) | (1,313.71) | (1,346.43) | (1,324.84) |
| Total Equity | 286.89 | 312.62 | 280.47 | 294.99 |
| LTM | 12/31/25 | 12/31/24 | 12/31/23 | 12/31/22 | |
|---|---|---|---|---|---|
| Cash & Equivalents | 288.19 | 307.53 | 471.39 | 618.83 | 710.41 |
| Receivables | — | — | 0.00 | 5.16 | 0.00 |
| Other Current Assets | 3.82 | 7.66 | 14.02 | 15.29 | 8.69 |
| Total Current Assets | 292.01 | 315.19 | 485.41 | 639.28 | 719.10 |
| Net PPE | 2.49 | 2.14 | 3.08 | 3.84 | 1.73 |
| Operating Lease ROU | 6.74 | 8.12 | 10.71 | 12.16 | 6.28 |
| Other Assets | — | — | 47.91 | 41.10 | 30.93 |
| Total Assets | 302.58 | 326.80 | 547.11 | 696.38 | 758.03 |
| Accounts Payable | 1.94 | 5.88 | 7.77 | 25.39 | 9.27 |
| Current Lease Liabilities | 2.96 | 2.89 | 2.61 | 1.11 | 6.47 |
| Other Current Liabilities | 6.76 | 32.08 | 38.12 | 30.39 | 34.40 |
| Total Current Liabilities | 11.66 | 40.84 | 48.50 | 56.89 | 50.15 |
| Long-term Lease Liabilities | 4.03 | 5.49 | 8.23 | 10.72 | 0.00 |
| Other Liabilities | — | — | 3.45 | 67.41 | 85.85 |
| Total Liabilities | 15.69 | 46.33 | 60.18 | 135.02 | 135.99 |
| Retained Earnings | (1,332.30) | (1,346.43) | (1,102.34) | (980.03) | (833.00) |
| Total Equity | 286.89 | 280.47 | 486.93 | 561.37 | 622.04 |
| 6/30/26 | 3/31/26 | 12/31/25 | 9/30/25 | |
|---|---|---|---|---|
| Net Income | (18.58) | 32.72 | (21.59) | (36.54) |
| D&A | 0.20 | 0.18 | 0.22 | 0.23 |
| Stock-Based Comp | 7.88 | 6.92 | 7.07 | 7.20 |
| Δ Working Cap & Other | (14.54) | (10.94) | (9.02) | (11.45) |
| Operating Cash Flow | (25.05) | 28.88 | (23.31) | (40.56) |
| Other Investing | (0.65) | — | — | — |
| Investing Cash Flow | (0.65) | 0.00 | 0.00 | (0.01) |
| Other Financing | (15.57) | (6.95) | — | — |
| Financing Cash Flow | (15.57) | (6.95) | 0.00 | (0.02) |
| LTM | 12/31/25 | 12/31/24 | 12/31/23 | 12/31/22 | |
|---|---|---|---|---|---|
| Net Income | (43.99) | (244.09) | (122.31) | (147.03) | (116.95) |
| D&A | 0.83 | 0.90 | 0.89 | 0.93 | 0.74 |
| Stock-Based Comp | 29.07 | 37.64 | 45.96 | 40.91 | 31.32 |
| Δ Working Cap & Other | (45.95) | 41.98 | (74.60) | (28.72) | (23.94) |
| Operating Cash Flow | (60.05) | (163.58) | (150.05) | (133.91) | (108.82) |
| Other Investing | (0.66) | — | — | (2.77) | — |
| Investing Cash Flow | (0.66) | (0.14) | (0.30) | (2.77) | (0.46) |
| Other Financing | (22.53) | — | 1.55 | 45.10 | 241.46 |
| Financing Cash Flow | (22.53) | (0.14) | 1.55 | 45.10 | 241.46 |
| 6/30/26 | 3/31/26 | 12/31/25 | 9/30/25 | |
|---|---|---|---|---|
| Current Ratio | 25.05 | 10.43 | 7.72 | 6.61 |
| Quick Ratio | — | — | — | — |
| Debt / Equity | 0.05 | 0.12 | 0.17 | 0.20 |
| EBITDA Margin % | (2069.7%) | 59.2% | (114214.3%) | (1656.8%) |
| Working Capital | 280.36 | 306.68 | 274.35 | 288.54 |
| Net Debt | — | — | — | — |
| ROE % | (6.5%) | 10.5% | (7.7%) | (12.4%) |
| ROA % | (6.1%) | 9.4% | (6.6%) | (10.4%) |
| LTM | 12/31/25 | 12/31/24 | 12/31/23 | 12/31/22 | |
|---|---|---|---|---|---|
| Current Ratio | 25.05 | 7.72 | 10.01 | 11.24 | 14.34 |
| Quick Ratio | — | — | — | — | — |
| Debt / Equity | 0.05 | 0.17 | 0.12 | 0.24 | 0.22 |
| EBITDA Margin % | (100.3%) | (2207.2%) | (113.7%) | (208.1%) | (242.7%) |
| Working Capital | 280.36 | 274.35 | 436.91 | 582.39 | 668.95 |
| Net Debt | — | — | — | — | — |
| ROE % | (15.3%) | (87.0%) | (25.1%) | (26.2%) | (18.8%) |
| ROA % | (14.5%) | (74.7%) | (22.4%) | (21.1%) | (15.4%) |
Insider activity (last 2 years)
| Date Filed | Reporter | Relationship | Trans. Date | Code | Shares | Price | Total Value |
|---|---|---|---|---|---|---|---|
| 2026-08-10 | SCULLY WILLIAM P | 10% Owner | 2026-08-07 | P | 34,000 | $8.62 | $293,053 |
| 2026-08-10 | SCULLY WILLIAM P | 10% Owner | 2026-08-07 | P | 3,500 | $8.62 | $30,167 |
| 2026-07-30 | Kingston Anne Evans | Officer (Chief Strategy Officer) | 2026-07-29 | S | (7,662) | $8.47 | -$64,919 |
| 2026-07-30 | Isaacs Michael John | Officer (General Counsel & Company Sec.) | 2026-07-29 | S | (8,386) | $8.47 | -$71,055 |
| 2026-07-30 | Zago Wagner M. | Officer (Chief Scientific Officer) | 2026-07-28 | M | 51,000 | — | $0 |
| 2026-07-30 | Zago Wagner M. | Officer (Chief Scientific Officer) | 2026-07-28 | D | (51,000) | $8.56 | -$436,560 |
| 2026-07-30 | Zago Wagner M. | Officer (Chief Scientific Officer) | 2026-07-28 | M | (51,000) | — | $-0 |
| 2026-07-30 | Walker Karin L | Officer (Chief Accounting Officer) | 2026-07-28 | M | 15,000 | — | $0 |
| 2026-07-30 | Walker Karin L | Officer (Chief Accounting Officer) | 2026-07-28 | D | (15,000) | $8.56 | -$128,400 |
| 2026-07-30 | Walker Karin L | Officer (Chief Accounting Officer) | 2026-07-28 | M | (15,000) | — | $-0 |
| 2026-07-30 | Swanson Chad J. | Officer (Chief Development Officer) | 2026-07-28 | M | 51,000 | — | $0 |
| 2026-07-30 | Swanson Chad J. | Officer (Chief Development Officer) | 2026-07-28 | D | (40,800) | $8.56 | -$349,248 |
| 2026-07-30 | Swanson Chad J. | Officer (Chief Development Officer) | 2026-07-28 | F | (3,467) | $8.56 | -$29,678 |
| 2026-07-30 | Swanson Chad J. | Officer (Chief Development Officer) | 2026-07-28 | M | (51,000) | — | $-0 |
| 2026-07-30 | Smith Brandon S. | Officer (Chief Operating Officer) | 2026-07-28 | M | 78,000 | — | $0 |
| 2026-07-30 | Smith Brandon S. | Officer (Chief Operating Officer) | 2026-07-28 | D | (78,000) | $8.56 | -$667,680 |
| 2026-07-30 | Smith Brandon S. | Officer (Chief Operating Officer) | 2026-07-28 | M | (78,000) | — | $-0 |
| 2026-07-30 | Nguyen Tran | Officer (Chief Strategy Officer and CFO) | 2026-07-28 | M | 57,000 | — | $0 |
| 2026-07-30 | Nguyen Tran | Officer (Chief Strategy Officer and CFO) | 2026-07-28 | D | (57,000) | $8.56 | -$487,920 |
| 2026-07-30 | Nguyen Tran | Officer (Chief Strategy Officer and CFO) | 2026-07-28 | M | (57,000) | — | $-0 |
| 2026-07-30 | Kinney Gene G. | Director, Officer (President and CEO) | 2026-07-28 | M | 84,000 | — | $0 |
| 2026-07-30 | Kinney Gene G. | Director, Officer (President and CEO) | 2026-07-28 | D | (84,000) | $8.56 | -$719,040 |
| 2026-07-30 | Kinney Gene G. | Director, Officer (President and CEO) | 2026-07-28 | M | (84,000) | — | $-0 |
| 2026-07-30 | Kingston Anne Evans | Officer (Chief Strategy Officer) | 2026-07-28 | F | (3,498) | $8.56 | -$29,943 |
| 2026-07-30 | Isaacs Michael John | Officer (General Counsel & Company Sec.) | 2026-07-28 | F | (4,694) | $8.56 | -$40,181 |
| 2026-06-18 | SCULLY WILLIAM P | 10% Owner | 2026-06-16 | P | 20,000 | $7.90 | $157,990 |
| 2026-06-16 | SCULLY WILLIAM P | 10% Owner | 2026-06-15 | G | (325,000) | — | $-0 |
| 2026-06-12 | SCULLY WILLIAM P | 10% Owner | 2026-06-11 | P | 125,000 | $8.17 | $1,021,225 |
| 2026-06-05 | SCULLY WILLIAM P | 10% Owner | 2026-06-04 | P | 50,000 | $9.31 | $465,295 |
| 2026-06-03 | SCULLY WILLIAM P | 10% Owner | 2026-06-02 | P | 50,000 | $9.43 | $471,300 |
| 2026-05-26 | SCULLY WILLIAM P | 10% Owner | 2026-05-22 | P | 100,000 | $9.81 | $981,300 |
| 2026-05-15 | WELCH DANIEL G | Director | 2026-05-15 | A | 27,000 | — | $0 |
| 2026-05-15 | Selkoe Dennis J. | Director | 2026-05-15 | A | 27,000 | — | $0 |
| 2026-05-15 | Ekman Lars | Director | 2026-05-15 | A | 27,000 | — | $0 |
| 2026-05-15 | Dunn William H. Jr. | Director | 2026-05-15 | A | 27,000 | — | $0 |
| 2026-05-15 | Cooke Shane | Director | 2026-05-15 | A | 27,000 | — | $0 |
| 2026-05-15 | COLLIER RICHARD T | Director | 2026-05-15 | A | 27,000 | — | $0 |
| 2026-04-10 | Kingston Anne Evans | Officer (Chief Strategy Officer) | 2026-04-10 | A | 100,000 | — | $0 |
| 2026-03-05 | Zago Wagner M. | Officer (Chief Scientific Officer) | 2026-03-03 | A | 190,000 | — | $0 |
| 2026-03-05 | Walker Karin L | Officer (Chief Accounting Officer) | 2026-03-03 | A | 150,000 | — | $0 |
| 2026-03-05 | Swanson Chad J. | Officer (Chief Development Officer) | 2026-03-03 | A | 190,000 | — | $0 |
| 2026-03-05 | Smith Brandon S. | Officer (Chief Operating Officer) | 2026-03-03 | A | 190,000 | — | $0 |
| 2026-03-05 | Nguyen Tran | Officer (Chief Strategy Officer and CFO) | 2026-03-03 | A | 230,000 | — | $0 |
| 2026-03-05 | Malecek Michael J | Officer (Chief Legal Officer) | 2026-03-03 | A | 190,000 | — | $0 |
| 2026-03-05 | Kinney Gene G. | Director, Officer (President and CEO) | 2026-03-03 | A | 520,000 | — | $0 |
| 2025-07-30 | Zago Wagner M. | Officer (Chief Scientific Officer) | 2025-07-28 | A | 85,000 | — | $0 |
| 2025-07-30 | Walker Karin L | Officer (Chief Accounting Officer) | 2025-07-28 | A | 25,000 | — | $0 |
| 2025-07-30 | Swanson Chad J. | Officer (Chief Development Officer) | 2025-07-28 | A | 85,000 | — | $0 |
| 2025-07-30 | Smith Brandon S. | Officer (Chief Operating Officer) | 2025-07-28 | A | 130,000 | — | $0 |
| 2025-07-30 | Nguyen Tran | Officer (Chief Strategy Officer and CFO) | 2025-07-28 | A | 95,000 | — | $0 |
| 2025-07-30 | Malecek Michael J | Officer (Chief Legal Officer) | 2025-07-28 | A | 80,000 | — | $0 |
| 2025-07-30 | Kinney Gene G. | Director, Officer (President and CEO) | 2025-07-28 | A | 140,000 | — | $0 |
| 2025-05-16 | WELCH DANIEL G | Director | 2025-05-14 | A | 20,183 | — | $0 |
| 2025-05-16 | Selkoe Dennis J. | Director | 2025-05-14 | A | 20,183 | — | $0 |
| 2025-05-16 | Kim Helen Susan | Director | 2025-05-14 | A | 20,183 | — | $0 |
| 2025-05-16 | Ekman Lars | Director | 2025-05-14 | A | 20,183 | — | $0 |
| 2025-05-16 | Dunn William H. Jr. | Director | 2025-05-14 | A | 20,183 | — | $0 |
| 2025-05-16 | Cooke Shane | Director | 2025-05-14 | A | 20,183 | — | $0 |
| 2025-05-16 | COLLIER RICHARD T | Director | 2025-05-14 | A | 20,183 | — | $0 |
| 2025-05-16 | Cobb Paula K | Director | 2025-05-14 | A | 20,183 | — | $0 |
| 2025-05-06 | EcoR1 Capital, LLC | 10% Owner | 2025-05-06 | S | (1,984,053) | $7.64 | -$15,164,712 |
| 2025-05-06 | EcoR1 Capital, LLC | 10% Owner | 2025-05-05 | S | (977,693) | $8.11 | -$7,930,166 |
| 2025-05-06 | EcoR1 Capital, LLC | 10% Owner | 2025-05-02 | S | (3,317,938) | $8.36 | -$27,744,929 |
| 2025-05-02 | SCULLY WILLIAM P | 10% Owner | 2025-01-15 | G | (12,000) | — | $-0 |
| 2025-05-02 | SCULLY WILLIAM P | 10% Owner | 2025-01-14 | P | 100,000 | $12.79 | $1,279,040 |
| 2025-05-02 | SCULLY WILLIAM P | 10% Owner | 2025-01-03 | G | (1,000) | — | $-0 |
| 2025-05-02 | SCULLY WILLIAM P | 10% Owner | 2025-01-02 | G | (13,200) | — | $-0 |
| 2025-05-02 | SCULLY WILLIAM P | 10% Owner | 2024-12-31 | P | 1,200 | $13.37 | $16,038 |
| 2025-05-02 | SCULLY WILLIAM P | 10% Owner | 2024-12-31 | P | 800 | $13.39 | $10,715 |
| 2025-05-02 | SCULLY WILLIAM P | 10% Owner | 2024-12-31 | P | 30,000 | $12.99 | $389,640 |
| 2025-05-02 | SCULLY WILLIAM P | 10% Owner | 2024-12-20 | P | 2,000 | $15.91 | $31,813 |
| 2025-05-02 | SCULLY WILLIAM P | 10% Owner | 2024-12-20 | G | (500) | — | $-0 |
| 2025-05-02 | SCULLY WILLIAM P | 10% Owner | 2024-12-20 | G | (40,000) | — | $-0 |
| 2025-05-02 | SCULLY WILLIAM P | 10% Owner | 2024-12-19 | G | (681,000) | — | $-0 |
| 2025-05-02 | SCULLY WILLIAM P | 10% Owner | 2024-12-18 | G | 430,000 | — | $0 |
| 2025-05-02 | SCULLY WILLIAM P | 10% Owner | 2024-12-18 | P | 73,436 | $13.93 | $1,022,670 |
| 2025-03-07 | Zago Wagner M. | Officer (Chief Scientific Officer) | 2025-03-05 | A | 107,500 | — | $0 |
| 2025-03-07 | Walker Karin L | Officer (Chief Accounting Officer) | 2025-03-05 | A | 70,000 | — | $0 |
| 2025-03-07 | Swanson Chad J. | Officer (Chief Development Officer) | 2025-03-05 | A | 107,500 | — | $0 |
| 2025-03-07 | Smith Brandon S. | Officer (Chief Operating Officer) | 2025-03-05 | A | 107,500 | — | $0 |
| 2025-03-07 | Nguyen Tran | Officer (Chief Strategy Officer and CFO) | 2025-03-05 | A | 107,500 | — | $0 |
| 2025-03-07 | Malecek Michael J | Officer (Chief Legal Officer) | 2025-03-05 | A | 107,500 | — | $0 |
| 2025-03-07 | Kinney Gene G. | Director, Officer (President and CEO) | 2025-03-05 | A | 375,000 | — | $0 |
| 2025-03-07 | Karp Carol D. | Officer (Chief Regulatory Officer) | 2025-03-05 | A | 107,500 | — | $0 |
| 2025-03-07 | Ford David A | Officer (Chief People Officer) | 2025-03-05 | A | 107,500 | — | $0 |
| 2025-02-14 | Nguyen Tran | Officer (Chief Strategy Officer and CFO) | 2020-04-08 | J | (995) | — | $-0 |
| 2024-10-03 | Swanson Chad J. | Officer (Chief Development Officer) | 2024-10-01 | A | 40,000 | — | $0 |